Biotech Values

[Aiming4]

GTCB post approval valuation...

#msg-8514007
I continue to believe that $200M is an unduly conservative post-approval valuation. Whether the post-approval valuation will get higher than this I cannot say, but I think it ought to in due course. JMHO, FWIW

Dew - did I read this correctly that you see some chance that GTCB pps may initially stay flat or only see a modest price jump with a favorable EMEA decision?... Aiming4.